The Gastroenterological Society of Australia (GESA) is urging the Federal Government to prioritise liver cancer including through the funding of checkpoint inhibitors. GESA spokesman Professor Darrell Crawford told the limbic that while many hepatologists haven’t yet had experience with immunotherapies, the profession was keen to maintain its leadership role in the multidisciplinary care of patients. ...
Liver cancer treatment requires team effort
30 Nov 2017